Life Science

A potent inhibitor of FAAH, with an IC₅₀ of 9.1 nM also inhibits MAGL at ~1,000-fold higher concentration (IC₅₀ = 7.9 &muM).

A potent inhibitor of FAAH, with an IC₅₀ of 9.1 nM also inhibits MAGL at ~1,000-fold higher concentration (IC₅₀ = 7.9 &muM).

A potent inhibitor of FAAH, with an IC₅₀ of 9.1 nM also inhibits MAGL at ~1,000-fold higher concentration (IC₅₀ = 7.9 &muM).

4-1BB(CD137) is a member of the tumor necrosis factor (TNF) receptor family. Its alternative names are tumor necrosis factor receptor superfamily member 9 (TNFRSF9), 4-1BB and induced by lymphocyte activation (ILA).

4-1BB(CD137) is a member of the tumor necrosis factor (TNF) receptor family. Its alternative names are tumor necrosis factor receptor superfamily member 9 (TNFRSF9), 4-1BB and induced by lymphocyte activation (ILA).

4-1BB Receptor, also named TNFRSF9 is a member of the TNF superfamily of receptors. It is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines.

4-1BB Receptor, also named TNFRSF9 is a member of the TNF superfamily of receptors. It is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines.

4-1BB Receptor, also named TNFRSF9 is a member of the TNF superfamily of receptors. It is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines.

A synthetic intermediate for pharmaceutical synthesis.

A synthetic intermediate for pharmaceutical synthesis.

A synthetic intermediate for pharmaceutical synthesis.

A synthetic intermediate useful for pharmaceutical synthesis.